Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A novel role for central ACBP/DBI as a regulator of long‐chain fatty acid metabolism in astrocytes

View through CrossRef
AbstractAcyl‐CoA‐binding protein (ACBP) is a ubiquitously expressed protein that binds intracellular acyl‐CoA esters. Several studies have suggested that ACBP acts as an acyl‐CoA pool former and regulates long‐chain fatty acids (LCFA) metabolism in peripheral tissues. In the brain, ACBP is known as Diazepam‐Binding Inhibitor, a secreted peptide acting as an allosteric modulator of the GABAA receptor. However, its role in central LCFA metabolism remains unknown. In the present study, we investigated ACBP cellular expression, ACBP regulation of LCFA intracellular metabolism, FA profile, and FA metabolism‐related gene expression using ACBP‐deficient and control mice. ACBP was mainly found in astrocytes with high expression levels in the mediobasal hypothalamus. We demonstrate that ACBP deficiency alters the central LCFA‐CoA profile and impairs unsaturated (oleate, linolenate) but not saturated (palmitate, stearate) LCFA metabolic fluxes in hypothalamic slices and astrocyte cultures. In addition, lack of ACBP differently affects the expression of genes involved in FA metabolism in cortical versus hypothalamic astrocytes. Finally, ACBP deficiency increases FA content and impairs their release in response to palmitate in hypothalamic astrocytes. Collectively, these findings reveal for the first time that central ACBP acts as a regulator of LCFA intracellular metabolism in astrocytes. image Acyl‐CoA‐binding protein (ACBP) or diazepam‐binding inhibitor is a secreted peptide acting centrally as a GABAA allosteric modulator. Using brain slices, cortical, and hypothalamic astrocyte cultures from ACBP KO mice, we demonstrate that ACBP mainly localizes in astrocytes and regulates unsaturated but not saturated long‐chain fatty acids (LCFA) metabolism. In addition, ACBP deficiency alters FA metabolism‐related genes and results in intracellular FA accumulation while affecting their release. Our results support a novel role for ACBP in brain lipid metabolism. FA, fatty acids; KO, knockout; PL, phospholipids; TAG, triacylglycerol.
Title: A novel role for central ACBP/DBI as a regulator of long‐chain fatty acid metabolism in astrocytes
Description:
AbstractAcyl‐CoA‐binding protein (ACBP) is a ubiquitously expressed protein that binds intracellular acyl‐CoA esters.
Several studies have suggested that ACBP acts as an acyl‐CoA pool former and regulates long‐chain fatty acids (LCFA) metabolism in peripheral tissues.
In the brain, ACBP is known as Diazepam‐Binding Inhibitor, a secreted peptide acting as an allosteric modulator of the GABAA receptor.
However, its role in central LCFA metabolism remains unknown.
In the present study, we investigated ACBP cellular expression, ACBP regulation of LCFA intracellular metabolism, FA profile, and FA metabolism‐related gene expression using ACBP‐deficient and control mice.
ACBP was mainly found in astrocytes with high expression levels in the mediobasal hypothalamus.
We demonstrate that ACBP deficiency alters the central LCFA‐CoA profile and impairs unsaturated (oleate, linolenate) but not saturated (palmitate, stearate) LCFA metabolic fluxes in hypothalamic slices and astrocyte cultures.
In addition, lack of ACBP differently affects the expression of genes involved in FA metabolism in cortical versus hypothalamic astrocytes.
Finally, ACBP deficiency increases FA content and impairs their release in response to palmitate in hypothalamic astrocytes.
Collectively, these findings reveal for the first time that central ACBP acts as a regulator of LCFA intracellular metabolism in astrocytes.
image Acyl‐CoA‐binding protein (ACBP) or diazepam‐binding inhibitor is a secreted peptide acting centrally as a GABAA allosteric modulator.
Using brain slices, cortical, and hypothalamic astrocyte cultures from ACBP KO mice, we demonstrate that ACBP mainly localizes in astrocytes and regulates unsaturated but not saturated long‐chain fatty acids (LCFA) metabolism.
In addition, ACBP deficiency alters FA metabolism‐related genes and results in intracellular FA accumulation while affecting their release.
Our results support a novel role for ACBP in brain lipid metabolism.
FA, fatty acids; KO, knockout; PL, phospholipids; TAG, triacylglycerol.

Related Results

Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
AbstractNeurodegenerative disorders, including chemotherapy-induced cognitive impairment, are associated with neuronal mitochondrial dysfunction. Cisplatin, a commonly used chemoth...
Circulating diazepam‐binding inhibitor in infancy: Relation to markers of adiposity and metabolic health
Circulating diazepam‐binding inhibitor in infancy: Relation to markers of adiposity and metabolic health
SummaryBackgroundDiazepam‐binding inhibitor (DBI) controls feeding behaviour and glucose homeostasis. Individuals born small‐for‐gestational‐age (SGA) with excessive postnatal catc...
Fatty Acid Incorporation into Human Adipose Tissue in Hypertrigiyceridaemia*
Fatty Acid Incorporation into Human Adipose Tissue in Hypertrigiyceridaemia*
AbstractThe fatty acid and glucose incorporation into glycerides and glycerol release from adipose tissue were determined in a middle‐aged population of 109 men and 41 women. 43 me...
Amides, Fatty Acid
Amides, Fatty Acid
AbstractFatty acid amides, which contain a saturated or unsaturated alkyl chain derived from a fatty acid, can be divided into three categories. The first is primary monoamides in ...
Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein
Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein
The relationship between altered metabolism of the amyloid-β precursor protein (APP) and Alzheimer's disease is well established but the physiological roles of APP still remain unc...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Basolateral amygdala astrocytes modulate of diabetic neuropathic pain and may be a potential therapeutic target for koumine
Basolateral amygdala astrocytes modulate of diabetic neuropathic pain and may be a potential therapeutic target for koumine
Background and Purpose: New remedies are required for the treatment of diabetic neuropathic pain (DNP) due to insufficient efficacy of available therapies. Here, we used chemogenet...

Back to Top